Bridgeway Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-52,400
| Closed | -$576K | – | 1482 |
|
|
2017
Q2 | $576K | Hold |
52,400
| – | – | 0.01% | 1042 |
|
|
2017
Q1 | $514K | Hold |
52,400
| – | – | 0.01% | 1067 |
|
|
2016
Q4 | $566K | Buy |
52,400
+10,300
| +24% | +$111K | 0.01% | 1047 |
|
|
2016
Q3 | $432K | Sell |
42,100
-550
| -1% | -$5.64K | 0.01% | 1147 |
|
|
2016
Q2 | $557K | Sell |
42,650
-12,500
| -23% | -$163K | 0.01% | 998 |
|
|
2016
Q1 | $607K | Sell |
55,150
-171,800
| -76% | -$1.89M | 0.01% | 966 |
|
|
2015
Q4 | $2.09M | Buy |
226,950
+16,700
| +8% | +$154K | 0.04% | 487 |
|
|
2015
Q3 | $1.46M | Buy |
210,250
+43,600
| +26% | +$303K | 0.03% | 587 |
|
|
2015
Q2 | $1.64M | Hold |
166,650
| – | – | 0.03% | 588 |
|
|
2015
Q1 | $1.48M | Hold |
166,650
| – | – | 0.03% | 638 |
|
|
2014
Q4 | $1.46M | Hold |
166,650
| – | – | 0.03% | 637 |
|
|
2014
Q3 | $1.15M | Hold |
166,650
| – | – | 0.03% | 705 |
|
|
2014
Q2 | $877K | Buy |
166,650
+4,900
| +3% | +$25.8K | 0.02% | 823 |
|
|
2014
Q1 | $736K | Buy |
161,750
+50,000
| +45% | +$228K | 0.02% | 897 |
|
|
2013
Q4 | $563K | Hold |
111,750
| – | – | 0.02% | 990 |
|
|
2013
Q3 | $567K | Buy |
+111,750
| New | +$567K | 0.02% | 967 |
|